Salarius Pharmaceuticals
SLRX
SLRX
51 hedge funds and large institutions have $64.9M invested in Salarius Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 10 closing their positions.
Holders
51
Holders Change
-6
Holders Change %
-10.53%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
22
Reduced
11
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$9.18M |
| 2 |
2
Primecap Management
Pasadena,
California
|
$6.96M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$3.34M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$3.11M |
| 5 |
5
Jennison Associates
New York
|
$7.57M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Geode Capital Management
Boston,
Massachusetts
| $710 | 64,788 | -54 | -0.1% |
|
52
Capital World Investors
Los Angeles,
California
| – | – | -357,562 | Closed |
|
|
LOAMU
53
Lombard Odier Asset Management (USA)
New York
| – | – | -113,630 | Closed |
|
|
ACP
54
Acuta Capital Partners
Redwood City,
California
| – | – | -88,716 | Closed |
|
|
NIP
55
Nicholas Investment Partners
Rancho Santa Fe,
California
| – | – | -57,035 | Closed |
|
56
Two Sigma Investments
New York
| – | – | -24,984 | Closed |
|
57
Citadel Advisors
Miami,
Florida
| – | – | -4,778 | Closed |
|
|
GGHC
58
Gilder Gagnon Howe & Co
New York
| – | – | -3,301 | Closed |
|
59
UBS Group
Zurich,
Switzerland
| – | – | -1,371 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | – | -412 | Closed |
|
|
MTIP
61
Magee Thomson Investment Partners
San Diego,
California
| – | – | -375 | Closed |
|